• Fall Clinical Cross Border Talk: A Breakthrough in Acne Sebum Reduction with Dr. Zoe Draelos & Dr. Andrei Metelitsa

  • Jan 20 2025
  • Duración: 29 m
  • Podcast

Fall Clinical Cross Border Talk: A Breakthrough in Acne Sebum Reduction with Dr. Zoe Draelos & Dr. Andrei Metelitsa

  • Resumen

  • Lights, laughter, and lasers on sebum?! 🤔 Absolutely!Join us for our first-ever Skin and Joints Podcast episode live at Fall Clinical 2024 in sunny Las Vegas. 🎰 We’re unveiling our new segment “Cross-Border Talk,” featuring Dr. Zoe Diana Dreyloos (reformed mechanical engineer ✈️ from North Carolina) and Dr. Andrei Medlitsa US-based dermatologist (hello, North Carolina!) and a Canadian colleague (brrr, Calgary!) trade professional pearls and unique perspectives on acne care.Expect runway-ready insights on:The big reveal of Clascoterone cream’s impact on sebum production (yep, they used a “sebum meter!”)Brand-new data showing significant improvements in both inflammatory and non-inflammatory acne lesionsThe “golden ticket” to fine dining in Vegas, plus confessions of flight fantasies (hint: not all high-flying action happens at the blackjack table)If you’re tired of your patients asking, “Doc, how do I zap this shine?”—this is the episode for you. Because (despite the famous saying) what happens in Vegas definitely won’t stay in Vegas this time. Tune in for the scoop on everything from sebum science to top-secret bunker restaurants. 🍸Episode Learning ObjectivesUnderstand the central role of sebum production in acne pathogenesis and how it shapes therapeutic strategies.Evaluate the newly released 12-week clinical data on Clascoterone cream 1%—with measured impact on both inflammatory and non-inflammatory lesions.Discuss the safety and tolerability profile of Clascoterone, including real-world patient adherence considerations.Translate the study’s findings into everyday practice, identifying which acne patients might benefit most from sebum-targeted therapy.Explore future research directions, including combination approaches, longer-term outcomes, and potential applications in severe acne or pore-size reduction.Understand the pivotal role of sebum production in acne pathogenesis and how it shapes therapeutic decisions.Examine the newest 12-week clinical data on Clascoterone cream 1%—including its documented impact on both inflammatory and non-inflammatory acne lesions.Apply practical tips for integrating Clascoterone into real-world regimens, tackling oily skin head-on with confidence.Get ready to rethink your acne game plan…Get ready for an antioxidant masterclass 🤓✨— that’ll have you completely rethinking your recommendations! ABOUT Dr. Zoe Diana Draelos, MD, FAADDERMATOLOGIST, HIGH POINT, NORTH CAROLINAZoe Diana Draelos, MD, is a research and clinical board-certified dermatologist and a Fellow of the American Academy of Dermatology. She is in solo private practice in High Point, North Carolina, and a Consulting Professor of Dermatology at Duke University. In 1988, she founded Dermatology Consulting Services, PLLC, to initiate and perform research in aging skin, acne, rosacea, psoriasis, atopic dermatitis, actinic keratoses, eczema, and aesthetic procedures in the cosmetic, OTC drug, and pharmaceutical arenas. Prior to pursuing a medical career, Dr. Draelos completed an undergraduate degree in Mechanical Engineering and was elected a Rhodes Scholar. A member of Sigma Xi research honorary and Alpha Omega Alpha medical honorary, she is author of 14 books including Cosmetics in Dermatology and Hair Cosmetics. She is the editor of Cosmetic Dermatology: Products and Procedures (third edition) and Cosmeceuticals (fourth edition) with translations into 7 languages. She has contributed chapters to 44 textbooks, written 173 posters, served as the principal investigator on 982 studies, written 650 published papers, served on or contributed to 38 journal editorial boards, functioned as the editor-in-chief of the Journal of Cosmetic Dermatology for 10 years, and was a past member of the Board of Directors of the American Academy of Dermatology and the American Society for Dermatologic Surgery. She was elected Vice-President of the American Academy of Dermatology. She is recognized as a pioneer in cosmetic dermatology and received a lifetime achievement award from Health Beauty America for her research and the 2008 DermArts award for her contributions to dermatology. In 2010, she received the Albert Kligman Innovation Award and in 2016 she was awarded a Presidential Citation from the American Academy of Dermatology for her research contributions to advance the specialty. She received the prestigious Maison deNavarre award from the Society of Cosmetic Chemists for her contributions to the art and science of cosmetics in 2017. In 2019, she was the inaugural recipient of the Florence Wall Award from the Society of Cosmetics Chemists naming her as the most influential women in cosmetic science.ABOUT Dr. Andrei Metelitsa, MD, FRCPC, FAADDERMATOLOGIST, CALGARY, ABDr. Metelitsa is a Board-Certified Dermatologist in both Canada and United States and is currently a Clinical Professor at the University of Calgary's Faculty of Medicine. He graduated from medical school...
    Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre Fall Clinical Cross Border Talk: A Breakthrough in Acne Sebum Reduction with Dr. Zoe Draelos & Dr. Andrei Metelitsa

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.